Esther Latres

8.9k total citations · 2 hit papers
35 papers, 7.0k citations indexed

About

Esther Latres is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Esther Latres has authored 35 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Surgery. Recurrent topics in Esther Latres's work include Cancer-related Molecular Pathways (9 papers), Muscle Physiology and Disorders (8 papers) and Diabetes Management and Research (7 papers). Esther Latres is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), Muscle Physiology and Disorders (8 papers) and Diabetes Management and Research (7 papers). Esther Latres collaborates with scholars based in United States, Spain and Australia. Esther Latres's co-authors include David J. Glass, Trevor N. Stitt, George D. Yancopoulos, David M. Valenzuela, Brian Clarke, Erqian Na, Michele Pagano, William Poueymirou, Lorna Nuñez and Sue C. Bodine and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Esther Latres

33 papers receiving 6.9k citations

Hit Papers

Identification of Ubiquitin Ligases Required for Skeletal... 2001 2026 2009 2017 2001 2007 500 1000 1.5k 2.0k 2.5k

Peers

Esther Latres
Zarife Sahenk United States
Esther Latres
Citations per year, relative to Esther Latres Esther Latres (= 1×) peers Zarife Sahenk

Countries citing papers authored by Esther Latres

Since Specialization
Citations

This map shows the geographic impact of Esther Latres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Latres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Latres more than expected).

Fields of papers citing papers by Esther Latres

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Latres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Latres. The network helps show where Esther Latres may publish in the future.

Co-authorship network of co-authors of Esther Latres

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Latres. A scholar is included among the top collaborators of Esther Latres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Latres. Esther Latres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rickels, Michael R., Jason L. Gaglia, Philip J. O’Connell, et al.. (2025). Future Directions and Clinical Trial Considerations for Novel Islet β-Cell Replacement Therapies for Type 1 Diabetes. Diabetes. 74(9). 1452–1463.
3.
Latres, Esther, Carla J. Greenbaum, Colin Dayan, et al.. (2024). Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes. Diabetes. 73(6). 823–833. 15 indexed citations
4.
Ackeifi, Courtney, Randy L. Anderson, Roy W. Beck, et al.. (2024). TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial. Frontiers in Immunology. 15. 1470677–1470677. 10 indexed citations
5.
Giraldo, Jaime A., et al.. (2020). 3D Bioprinting and Translation of Beta Cell Replacement Therapies for Type 1 Diabetes. Tissue Engineering Part B Reviews. 27(3). 238–252. 14 indexed citations
6.
Latres, Esther, Daniel A. Finan, J L Greenstein, Aaron J. Kowalski, & Timothy J. Kieffer. (2019). Navigating Two Roads to Glucose Normalization in Diabetes: Automated Insulin Delivery Devices and Cell Therapy. Cell Metabolism. 29(3). 545–563. 76 indexed citations
7.
Doré, Anthony, Lawrence Miloscio, Esther Latres, et al.. (2016). Myostatin deficiency but not anti‐myostatin blockade induces marked proteomic changes in mouse skeletal muscle. PROTEOMICS. 16(14). 2019–2027. 13 indexed citations
8.
Latres, Esther, Lawrence Miloscio, Erqian Na, et al.. (2015). Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice. Skeletal Muscle. 5(1). 34–34. 114 indexed citations
9.
Cohen, Shenhav, Jeffrey J. Brault, Steven P. Gygi, et al.. (2009). During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. The Journal of Cell Biology. 185(6). 1083–1095. 472 indexed citations
10.
Latres, Esther, Ami R. Amini, Ashley A. Amini, et al.. (2004). Insulin-like Growth Factor-1 (IGF-1) Inversely Regulates Atrophy-induced Genes via the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR) Pathway. Journal of Biological Chemistry. 280(4). 2737–2744. 408 indexed citations
11.
Bodine, Sue C., Esther Latres, Susanne Baumhueter, et al.. (2001). Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy. Science. 294(5547). 1704–1708. 2828 indexed citations breakdown →
12.
Zindy, Frédérique, Willem den Besten, Bo Chen, et al.. (2001). Control of Spermatogenesis in Mice by the Cyclin D-Dependent Kinase Inhibitors p18 Ink4c and p19 Ink4d. Molecular and Cellular Biology. 21(9). 3244–3255. 93 indexed citations
13.
Latres, Esther, Douglas I. Lin, Edgard Graner, et al.. (2001). The de-ubiquitinating enzyme Unp interacts with the retinoblastoma protein. Oncogene. 20(39). 5538–5542. 26 indexed citations
14.
Latres, Esther. (2000). Limited overlapping roles of P15INK4b and P18INK4c cell cycle inhibitors in proliferation and tumorigenesis. The EMBO Journal. 19(13). 3496–3506. 209 indexed citations
15.
Latres, Esther, et al.. (1999). The human F box protein β-Trcp associates with the Cul1/Skp1 complex and regulates the stability of β-catenin. Oncogene. 18(4). 849–854. 383 indexed citations
16.
Brennan, MF, Daphna Pollack, E. S. Casper, et al.. (1995). Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas. British Journal of Cancer. 72(4). 986–991. 51 indexed citations
17.
Drobnjak, Marija, Esther Latres, Daphna Pollack, et al.. (1994). Prognostic Implications of p53 Nuclear Overexpression and High Proliferation Index of Ki-67 in Adult Soft-Tissue Sarcomas. JNCI Journal of the National Cancer Institute. 86(7). 549–554. 132 indexed citations
18.
Fernández–Löpez, José–Antonio, Esther Latres, Xavier Remesar, & M. Alemany. (1993). A radio-enzymatic method for the estimation of l-leucine-specific radioactivity. Journal of Biochemical and Biophysical Methods. 26(4). 291–297. 1 indexed citations
19.
Latres, Esther, José–Antonio Fernández–Löpez, Xavier Remesar, & M. Alemany. (1992). An enzymatic method for the estimation of L-leucine in rat blood. Journal of Biochemical and Biophysical Methods. 24(1-2). 39–44. 2 indexed citations
20.
Latres, Esther, et al.. (1992). Measurement of rat lung blood flow with labelled microspheres. Archives Internationales de Physiologie de Biochimie et de Biophysique. 100(3). 263–265. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026